March 14, 2018 Towards Bridging Translational Gap in Cardiotoxicity Prediction: an Application of Progressive Cardiac Risk Assessment Strategy in TdP Risk Assessment of Moxifloxacin
August 3, 2018 Quantitative Approach for Cardiac Risk Assessment and Interpretation in Tuberculosis Drug Development
February 28, 2018 Patient-Reported Outcome (PRO) Consortium Translation Process: Consensus Development of Updated Best Practices
January 22, 2018 Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effort
January 1, 2018 Development of a symptom-focused patient-reported outcome measure for functional dyspepsia: the Functional Dyspepsia Symptom Diary (FDSD)
Performance Assessment of New Urinary Translational Safety Biomarkers of Drug-induced Renal Tubular Injury in Tenofovir-treated Cynomolgus Monkeys and Beagle Dogs
Individual serum bile acid profiling in rats aids in human risk assessment of drug-induced liver injury due to BSEP inhibition
December 22, 2017 A Dynamic Map for Learning, Communicating, Navigating and Improving Therapeutic Development
December 22, 2017 Application of a Dynamic Map for Learning, Communicating, Navigating, and Improving Therapeutic Development
January 12, 2017 A Standardised Method for Interpreting the Association Between Mutations and Phenotypic Drug Resistance in Mycobacterium Tuberculosis
